InvestorsHub Logo

Snowy_Owl

10/21/23 1:00 PM

#399946 RE: loanranger #399943

Only four? I think IPIX shareholders can do better than that.

It's funny how people (4 of them so far this time) can find the time to express their feelings about my posts with juvenile cartoon images but can't muster a decent argument

frenchbroad

10/21/23 1:05 PM

#399947 RE: loanranger #399943

This is more funny. Of course you want only to be provocative:

Are there any assets of value to sell


Brilacidin
3 successful Phase 2 human trials
3 different maladies
3 different administration method

You do not agree with my opinion?
"Brilacidin is now among our best options to fight antimicrobial resistant strains of bacterial infections, one of the scariest global threats,” explained Vincenzo Carnevale, professor of research at CST’s Institute for Computational Molecular Science (ICMS). He noted that the last truly novel class of antimicrobial molecules—not an optimization of preexisting molecules—was approved by the U.S. Food and Drug Administration in 1987."
https://news.temple.edu/news/2021-12-14/michael-l-klein-wins-prestigious-john-scott-award
There are many many other independent observations like this on Brilacidin value. An other independent positive opinion on Brilacidin value will arrive in Athens on Monday. Of course you know this.

Does Ipix have any assets of value?? Pfft
https://scholar.google.com/scholar?hl=en&as_sdt=0%2C10&q=brilacidin&btnG=

backtoreality

10/22/23 7:12 AM

#399954 RE: loanranger #399943

Why would ppl on this board, that are not part of your crew, want to engage in your conversation when you're totally biased to the destruction of the company that you dont even own a share in?

For the most part no one cares what you think after 10 years of relentlessly soft bashing Ipix.